NxSTAGE MEDICAL, INC. (NASDAQ:NXTM) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07(d) of Form 8-K, how frequently NxStage Medical, Inc. (“NxStage”) will conduct future advisory stockholder votes on its named executive officers’ compensation (“say-on-pay votes”).
Item 5.07Submission of Matters to a Vote of Security Holders.
On May25, 2017, NxStage held its 2017 Annual Meeting of Stockholders at which stockholders, among other actions, conducted an advisory vote on the frequency of future say-on-pay votes. As previously reported, a majority of the votes cast on this proposal were cast in favor of holding such say-on-pay votes annually. In light of these voting results, NxStage will continue to conduct a say-on-pay vote annually. The next advisory stockholder vote on the frequency of future say-on-pay votes will occur no later than NxStage’s 2023 Annual Meeting of Stockholders.
About NxSTAGE MEDICAL, INC. (NASDAQ:NXTM)
NxStage Medical, Inc. is a medical technology company. The Company is engaged in the development, manufacturing and marketing of products and services for patients suffering from chronic or acute kidney failure. The Company operates through three segments: System One, In-Center and Services. It offers its products and services to various markets, such as home, critical care and in-center. The System One segment is engaged in the sale and rental of the System One and PureFlow SL dialysate preparation equipment, and the sale of disposable products in the home and critical care markets. The In-Center segment is engaged in the sale of blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease (ESRD) patients at dialysis clinics, and needles for apheresis. The Services segment offers dialysis services provided to patients at its NxStage Kidney Care dialysis centers.